Brief: XSpray Pharma Q3 Pre-Tax Loss At SEK 13.9 Mln

Xspray Pharma publ AB

26/10/2021 07:08

Oct 26 (Reuters) - XSpray Pharma AB (publ)  XSPRAY.ST :
    * XSPRAY PHARMA PUBLISHES INTERIM REPORT Q3, JANUARY –
SEPTEMBER
2021
    * 9-MONTH LOSS BEFORE TAX AMOUNTED TO SEK -44,754 THOUSAND
(-37,438)
    * Q3 LOSS BEFORE TAX AMOUNTED TO SEK -13,890 THOUSAND
(-11,560)


Further company coverage:  XSPRAY.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 6600;))